Wilms Tumor Market Report 2026

Wilms Tumor Market Overview

• Wilms Tumor market size has reached to $1.71 billion in 2025 • Expected to grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 4.6% • Growth Driver: The Increase In Pediatric Cancer Prevalence Fueling Growth Due To Improving Diagnosis And Treatment Options • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Wilms Tumor Market?

Wilms tumor is a type of kidney cancer that primarily affects children, typically under the age of 5. It is also known as nephroblastoma. The tumor develops in the kidneys, which filter waste from the blood and produce urine. Wilms tumor is characterized by abnormal growth of kidney cells, and it may cause symptoms such as an abdominal mass, pain, fever, hematuria (blood in the urine), and high blood pressure. The main types of wilms tumor are favorable histology and anaplastic histology. Favorable histology in Wilms tumors indicates better prognosis and response to treatment, with high success rates using surgery and chemotherapy. It is classified into various stages such as stage I, stage II, stage III, stage IV, and stage V, and is diagnosed with several diagnoses including physical examination, imaging tests, and lab tests. It is treated with various treatments such as surgery, chemotherapy, and radiation therapy and is used by several end-users including cancer research institutes, diagnostic laboratories, hospitals, and others.

What Is The Wilms Tumor Market Growth Forecast?

The wilms tumor market size is expected to see steady growth in the next few years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing adoption of personalized treatment strategies, rising investments in pediatric cancer research, expansion of advanced imaging and genetic testing, growing availability of targeted therapies, increasing global awareness of childhood cancers. Major trends in the forecast period include increasing use of precision oncology protocols, growing focus on early-stage detection methods, expansion of combination therapy regimens, enhanced integration of diagnostic and treatment planning, advancements in multimodal diagnostic approaches.

Global Wilms Tumor Market Segmentation

1) By Type: Favorable Histology, Anaplastic Histology 2) By Stage: Stage I, Stage II, Stage III, Stage IV, Stage V 3) By Diagnosis: Physical Examination, Imaging Tests, Lab Tests 4) By Treatment: Surgery, Chemotherapy, Radiation Therapy 5) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End-Users Subsegments: 1) By Favorable Histology: Unilateral Wilms Tumor, Bilateral Wilms Tumor, Nephroblastomatosis 2) By Anaplastic Histology: Diffuse Anaplastic Wilms Tumor, Focal Anaplastic Wilms Tumor, Mixed Anaplastic Wilms Tumor

What Are The Drivers Of The Wilms Tumor Market?

The increasing prevalence of pediatric cancer is expected to propel the growth of the Wilms tumor market going forward. Pediatric cancer refers to cancer that occurs in children aged 0–14 years, involving abnormal cell growth that can develop in various tissues and organs. The prevalence of pediatric cancer is due to exposure to environmental pollutants, genetic predispositions, infections, and immune system factors. Pediatric cancer cases provide crucial insights into early diagnosis, treatment, and genetic factors, improving survival rates. It helps to develop tailored therapies, enhancing outcomes and quality of life for affected children. For instance, in January 2025, according to the Cancer Network, a US-based cancer research organization, an estimated 9,550 children (aged 0–14 years) will be diagnosed with cancer, with 1,050 estimated to die from the disease. Therefore, the increasing prevalence of pediatric cancer is driving the growth of the Wilms tumor industry. The increasing healthcare expenditure is expected to propel the growth of the Wilms tumor market going forward. Healthcare expenditure refers to the total amount of financial resources spent on medical services, equipment, medications, and healthcare infrastructure within a given period. The increasing healthcare expenditure is due to rising chronic disease prevalence and the growing demand for advanced medical treatments. Increasing healthcare expenditure improves Wilms tumor treatment by funding early diagnosis, advanced therapies, and specialized care, leading to better survival rates. It supports research, cutting-edge techniques, and affordable targeted drugs for improved outcomes. For instance, in May 2024, according to the Office for National Statistics, a UK-based government agency, total healthcare expenditure increased by 5.6% in nominal terms from 2022 to 2023, up from a growth rate of 0.9% in 2022. Therefore, the increasing healthcare expenditure is driving the growth of the Wilms tumor industry.

Key Players In The Global Wilms Tumor Market

Major companies operating in the wilms tumor market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Exelixis Inc., Abcam plc, Sino Biological Inc., OriGene Technologies Inc., Cell Signaling Technology Inc., Proteintech Group Inc., Santa Cruz Biotechnology Inc., Novus Biologicals LLC, Pfizer Inc., Novartis AG, Bristol‑Myers Squibb Company, F. Hoffmann‑La Roche Ltd., GSK plc, Sanofi S A, AbbVie Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Bayer AG

What Are Latest Mergers And Acquisitions In The Wilms Tumor Market?

In August 2023, the Kidney Cancer Association (KCA), a US-based community dedicated to serving and empowering kidney cancer patients, partnered with the Wilms Cancer Foundation (WCF) to advance global awareness, research, and treatment for pediatric kidney cancer. The partnership aims to foster international collaboration, strengthen resources for healthcare professionals, promote early detection efforts, and support policy initiatives to improve pediatric kidney cancer outcomes. The Wilms Cancer Foundation (WCF) is a US-based organization that supports and represents the needs of children, families, and healthcare organizations affected by Wilms tumors.

Regional Outlook

North America was the largest region in the wilms tumor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Wilms Tumor Market?

The wilms tumor market consists of revenues earned by entities by providing services such as immunotherapy, post-treatment surveillance, psychosocial counseling, and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The wilms tumor market includes sales of targeted therapy drugs, immunotherapy drugs, genetic testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Wilms Tumor Market Report 2026?

The wilms tumor market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the wilms tumor industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.